Ocugen is developing the Indian COVID vaccine Covaxin in the US and has completed an immuno-bridging study with positive results. However, Peter Marks the head of the Center for Biologics Evaluation ...
FORT MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will present new research at the International Society ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback